Published Date: 19 Jun 2024
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features to include histochemistry, ...
Read Full News1.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
2.
Early palliative care billing up from 2010 to 2019 for advanced cancer
3.
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma
4.
Updates from the 2022 WHO classification of kidney epithelial tumors
5.
The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.
1.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
2.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
3.
Survival Rate Dynamics in Hematologic and Solid Malignancies
4.
What You Need To Know About Trametinib: A Miracle Cancer Treatment?
5.
The Benefits and Side Effects of Vidaza Syndrome
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
5.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation